SK13522003A3 - Injikovateľný pamidronát disodný a spôsob jeho prípravy - Google Patents
Injikovateľný pamidronát disodný a spôsob jeho prípravy Download PDFInfo
- Publication number
- SK13522003A3 SK13522003A3 SK1352-2003A SK13522003A SK13522003A3 SK 13522003 A3 SK13522003 A3 SK 13522003A3 SK 13522003 A SK13522003 A SK 13522003A SK 13522003 A3 SK13522003 A3 SK 13522003A3
- Authority
- SK
- Slovakia
- Prior art keywords
- acid
- pamidronate
- composition
- pharmaceutically acceptable
- solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28829301P | 2001-05-02 | 2001-05-02 | |
| PCT/US2002/013801 WO2002087592A1 (en) | 2001-05-02 | 2002-05-01 | Injectable pamidronate disodium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK13522003A3 true SK13522003A3 (sk) | 2004-04-06 |
Family
ID=23106515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1352-2003A SK13522003A3 (sk) | 2001-05-02 | 2002-05-01 | Injikovateľný pamidronát disodný a spôsob jeho prípravy |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6709674B2 (pt) |
| EP (1) | EP1390044A4 (pt) |
| BR (1) | BR0209361A (pt) |
| CA (1) | CA2445584A1 (pt) |
| CZ (1) | CZ20032951A3 (pt) |
| EE (1) | EE200300477A (pt) |
| HU (1) | HUP0400087A3 (pt) |
| MX (1) | MXPA03009890A (pt) |
| PL (1) | PL363537A1 (pt) |
| RU (1) | RU2003134700A (pt) |
| SK (1) | SK13522003A3 (pt) |
| WO (1) | WO2002087592A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1441674A (zh) * | 2000-09-18 | 2003-09-10 | 福荷福尔丁和考有限公司 | 二磷酸盐溶液 |
| CA2347330C (en) * | 2001-05-10 | 2002-03-12 | Pharmaceutical Partners Of Canada Inc. | Liquid injectable formulation of disodium pamidronate |
| MY141763A (en) * | 2003-09-18 | 2010-06-30 | Novartis Ag | Pharmaceutical products comprising bisphosphonates |
| US20060063720A1 (en) * | 2004-09-22 | 2006-03-23 | Edgar Schridde | Oxaliplatin solution concentrate |
| US20060063833A1 (en) * | 2004-09-22 | 2006-03-23 | Edgar Schridde | Ready-to-use oxaliplatin solutions |
| WO2006100687A1 (en) * | 2005-03-24 | 2006-09-28 | Dabur Pharma Ltd. | Disodium pamidronate aqueous formulation |
| WO2011163389A2 (en) * | 2010-06-25 | 2011-12-29 | The Trustees Of Columbia University In The City Of New York | Method for inducing fat loss in mammals |
| CN103040766B (zh) * | 2013-01-10 | 2015-09-02 | 罗诚 | 一种含有帕米磷酸二钠化合物的药物组合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2405254C2 (de) * | 1974-02-04 | 1982-05-27 | Henkel KGaA, 4000 Düsseldorf | Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper |
| US4639338A (en) | 1984-08-06 | 1987-01-27 | Ciba-Geigy Corporation | Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate |
| DE69907258T2 (de) * | 1998-12-10 | 2003-11-06 | Aesgen, Inc. | Verfahren zur herstellung von dinatriumpamidronat |
| US6160165A (en) | 1998-12-10 | 2000-12-12 | Aesgen, Inc. | Method for preparation of disodium pamidronate |
| AUPR018900A0 (en) | 2000-09-18 | 2000-10-12 | Fh Faulding Pty Limited | Pamidronate solution |
-
2002
- 2002-05-01 EE EEP200300477A patent/EE200300477A/xx unknown
- 2002-05-01 CZ CZ20032951A patent/CZ20032951A3/cs unknown
- 2002-05-01 US US10/137,205 patent/US6709674B2/en not_active Expired - Fee Related
- 2002-05-01 SK SK1352-2003A patent/SK13522003A3/sk not_active Application Discontinuation
- 2002-05-01 RU RU2003134700/15A patent/RU2003134700A/ru not_active Application Discontinuation
- 2002-05-01 HU HU0400087A patent/HUP0400087A3/hu unknown
- 2002-05-01 MX MXPA03009890A patent/MXPA03009890A/es active IP Right Grant
- 2002-05-01 EP EP02726828A patent/EP1390044A4/en not_active Withdrawn
- 2002-05-01 BR BR0209361-8A patent/BR0209361A/pt not_active IP Right Cessation
- 2002-05-01 PL PL02363537A patent/PL363537A1/xx not_active Application Discontinuation
- 2002-05-01 WO PCT/US2002/013801 patent/WO2002087592A1/en not_active Application Discontinuation
- 2002-05-01 CA CA002445584A patent/CA2445584A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1390044A1 (en) | 2004-02-25 |
| MXPA03009890A (es) | 2004-02-17 |
| EP1390044A4 (en) | 2005-03-23 |
| US20030069211A1 (en) | 2003-04-10 |
| RU2003134700A (ru) | 2005-03-20 |
| US6709674B2 (en) | 2004-03-23 |
| CA2445584A1 (en) | 2002-11-07 |
| EE200300477A (et) | 2003-12-15 |
| PL363537A1 (en) | 2004-11-29 |
| BR0209361A (pt) | 2004-06-08 |
| HUP0400087A3 (en) | 2007-05-29 |
| WO2002087592A1 (en) | 2002-11-07 |
| CZ20032951A3 (cs) | 2004-02-18 |
| HUP0400087A2 (hu) | 2004-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100910606B1 (ko) | 동결 건조된 판토프라졸 제제 및 판토프라졸 주사액 | |
| EP0759757B1 (en) | Oral liquid alendronate formulations | |
| EP2094308B1 (en) | Stable parenteral formulation containing a rsv inhibitor of a benzodiazepine structure | |
| US20230172953A1 (en) | Physiologically balanced injectable formulations of fosnetupitant | |
| SK13522003A3 (sk) | Injikovateľný pamidronát disodný a spôsob jeho prípravy | |
| WO2006082490A1 (en) | Injectable formulations of benzimidazole compounds | |
| US20150216928A1 (en) | Daptomycin injectable formulation | |
| CN117651548A (zh) | 冻干制剂溶液及冻干制剂、方法和用途 | |
| US20070191286A1 (en) | Injectable composition | |
| EP1667655B1 (en) | New use, pharmaceutical preparations as well as a process for their production | |
| JP2005200409A (ja) | 注射剤 | |
| AU2006235847C1 (en) | Lyophilized pantoprazole preparation | |
| RU2007152C1 (ru) | Офтальмологическое средство и способ его получения | |
| WO2022123510A1 (en) | Methisoprinol compositions | |
| TW202434259A (zh) | 凍乾製劑及與其相關的溶液、注射液、包裝和方法 | |
| TW202434258A (zh) | 溶液、凍乾製劑、凍乾製劑單位包裝、注射液及注射液配製方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC9A | Refused patent application |